Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis.
Tamura R, Yamanobe Y, Fujioka M, Morimoto Y, Fukumura M, Nakaya M, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ozawa H, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M.
Tamura R, et al. Among authors: ueda r.
J Clin Oncol. 2024 Jul 20;42(21):2578-2587. doi: 10.1200/JCO.23.02376. Epub 2024 May 22.
J Clin Oncol. 2024.
PMID: 38776485
Clinical Trial.